Erratum to HTR7 promotes laryngeal cancer growth through PI3K/AKT pathway activation
Erratum

Erratum to HTR7 promotes laryngeal cancer growth through PI3K/AKT pathway activation

Editorial Office

Annals of Translational Medicine

Correspondence to: Editorial Office. Annals of Translational Medicine. Email: editor@atmjournal.org.

Submitted Jul 08, 2022. Accepted for publication Jul 22, 2022.

doi: 10.21037/atm-2022-43


Erratum to: Ann Transl Med xxxx;9:840

This article (1) titled “HTR7 promotes laryngeal cancer growth through PI3K/AKT pathway activation” (doi: 10.21037/atm-21-1069), unfortunately contains an error in Figure 5, in which the wrong soft agar image was mistakenly used in the TU212/Scramble control for Figure 5A during figure assembly. Besides, the “Representational soft agar growth assay are” should be changed to “Representational soft agar growth assay is” in the legend of Figure 5. The correct Figure 5 and legend of Figure 5 can be found below.

Correct Figure 5:

Figure 5 5-hydroxytryptamine receptor 7 (HTR7) promotes laryngeal cancer growth. (A) Soft agar growth analysis of the effect of HTR7 overexpression or knockdown on cell growth. The colony size was determined using an ocular micrometer and colonies >0.1 mm in diameter were counted through a bright-field microscope under ×400 magnification. Representational soft agar growth assay is shown on the left; statistical analysis is shown on the right. (B) Animal model analysis of the effect of HTR7 overexpression or knockdown on cell growth. Representational soft agar growth assay is shown on the left; tumor volume analysis is shown on the right. Error bars represent the mean ± STDEV. *P<0.05.

The authors apologize for the oversight.

Click here to view the updated version of the article.

Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/.


References

  1. Sheng X, Liu W, Lu Z, et al. HTR7 promotes laryngeal cancer growth through PI3K/AKT pathway activation. Ann Transl Med 2021;9:840. [Crossref] [PubMed]
Cite this article as: Editorial Office. Erratum to HTR7 promotes laryngeal cancer growth through PI3K/AKT pathway activation. Ann Transl Med 2022;10(16):918. doi: 10.21037/atm-2022-43

Download Citation